BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15507393)

  • 1. The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock.
    Venet F; Lepape A; Debard AL; Bienvenu J; Bohé J; Monneret G
    Clin Immunol; 2004 Dec; 113(3):278-84. PubMed ID: 15507393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease.
    Cosmi L; Annunziato F; Galli MIG ; Maggi RME ; Nagata K; Romagnani S
    Eur J Immunol; 2000 Oct; 30(10):2972-9. PubMed ID: 11069080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
    Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
    Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
    Pérez-Novo CA; Holtappels G; Vinall SL; Xue L; Zhang N; Bachert C; Pettipher R
    Allergy; 2010 Mar; 65(3):304-10. PubMed ID: 19839971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
    Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective expression of a novel surface molecule by human Th2 cells in vivo.
    Nagata K; Tanaka K; Ogawa K; Kemmotsu K; Imai T; Yoshie O; Abe H; Tada K; Nakamura M; Sugamura K; Takano S
    J Immunol; 1999 Feb; 162(3):1278-86. PubMed ID: 9973380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway.
    Xue L; Barrow A; Pettipher R
    J Immunol; 2009 Jun; 182(12):7580-6. PubMed ID: 19494281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation.
    Takeshita K; Yamasaki T; Nagao K; Sugimoto H; Shichijo M; Gantner F; Bacon KB
    Int Immunol; 2004 Jul; 16(7):947-59. PubMed ID: 15173122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection of primary CD4+ Th2 cells, defined by expression of the chemoattractant receptor-homologous (CRTH2), induces a Th0 phenotype.
    Bahbouhi B; Landay A; Tenorio A; Al-Harthi L
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):269-77. PubMed ID: 17331033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
    Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
    Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of human allergen-specific CRTH2+ T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide.
    Annunziato F; Cosmi L; Manetti R; Brugnolo F; Parronchi P; Maggi E; Nagata K; Romagnani S
    J Allergy Clin Immunol; 2001 Nov; 108(5):815-21. PubMed ID: 11692110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa.
    Shirasaki H; Kikuchi M; Kanaizumi E; Himi T
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):110-5. PubMed ID: 19230460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor.
    El-Shazly AE; Moonen V; Mawet M; Begon D; Henket M; Arafa M; Louis R; Delvenne P; Lefebvre PP
    Int Immunopharmacol; 2011 Nov; 11(11):1864-70. PubMed ID: 21835268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
    Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
    Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.
    Gyles SL; Xue L; Townsend ER; Wettey F; Pettipher R
    Immunology; 2006 Nov; 119(3):362-8. PubMed ID: 17067313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).
    Liu F; Gonzalo JA; Manning S; O'Connell LE; Fedyk ER; Burke KE; Elder AM; Pulido JC; Cao W; Tayber O; Qiu Y; Ghosh S; Ocain TD; Hodge MR; Suzuki-Yagawa Y
    Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):133-47. PubMed ID: 15967168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2.
    Yamamoto M; Okano M; Fujiwara T; Kariya S; Higaki T; Nagatsuka H; Tsujigiwa H; Yamada M; Yoshino T; Urade Y; Nishizaki K
    Int Arch Allergy Immunol; 2009; 148(2):127-36. PubMed ID: 18802357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
    Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
    J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji's disease): a proposed mechanism of action.
    Satoh T; Shimura C; Miyagishi C; Yokozeki H
    Acta Derm Venereol; 2010; 90(1):18-22. PubMed ID: 20107720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.